Home › Funds › Renaissance Technologies › ELEV

Renaissance Technologies position in ELEV

ELEVATION ONCOLOGY INC

Latest position (Q2 2025)165.83K sh
Reported value held$60.88K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q4 2021 16.60K $100.00K New
Q1 2022 25.40K $64.00K Add
Q2 2022 258.40K $362.00K Add
Q3 2022 288.66K $326.00K Add
Q4 2022 199.90K $190 Reduce
Q1 2023 51.50K $98 Reduce
Q2 2023 16.80K $26 Reduce
Q4 2023 441.49K $237 New
Q3 2024 1.79M $1.07M New
Q4 2024 1.60M $902.02K Reduce
Q1 2025 647.30K $167.72K Reduce
Q2 2025 165.83K $60.88K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ELEV

No other tracked fund reports a position in ELEV.

All ELEV fund holders →